The safety and efficacy of cisatracurium 0.15 mg.kg-1 during nitrous oxide-opioid anaesthesia in infants and children

Anaesthesia

Volumn 55, Issue 11, 2000, Pages 1047-1051

  Taivainen, T ^a   Meakin, G H ^b   Meretoja, O A ^a   Wirtavuori, K ^a   Perkins, R J ^b   Murphy, A K ^b   Fisher, G R ^c   Waiter, M R D ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Anaesthesia: paediatric; Neuromuscular relaxants: cisatracurium; Pharmacodynamics

Indexed keywords

ALFENTANIL; CISATRACURIUM; MIDAZOLAM; NITROUS OXIDE; THIOPENTAL;

ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; CARDIOVASCULAR EFFECT; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROMUSCULAR FUNCTION; PEDIATRIC ANESTHESIA; PHASE 3 CLINICAL TRIAL;

ANESTHESIA, GENERAL; ANESTHETICS, COMBINED; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ATRACURIUM; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; FEMALE; HEART RATE; HUMANS; INFANT; MALE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NITROUS OXIDE;

EID: 0033692975     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2000.01623.x     Document Type: Article

References (18)

1. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia
2. 2-opioid anesthesia
3. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia
4. 2/propofol anesthesia
5. Evaluation of intubation at 90 and 120 seconds following 51W89 administration
6. Structure - Action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anaesthetized cat
7. Pharmacodynamic effects of 51W89, an isomer of atracurium, in children during halothane anaesthesia
8. Cisatracurium during halothane and balanced anaesthesia in children
9. Effects of cisatracurium in children during halothane-nitrous oxide anesthesia
10. Effects of 0.86 mg/kg cisatracurium in an infant
11. A novel format for a growth chart
12. Effect of surface electrode positioning on the compound action potential evoked by ulnar nerve stimulation in anaesthetized infants and children
13. Pharmacokinetics and pharmacodynamics of D-tubocurarine in infants, children and adults
14. Comparison of atracurium-induced neuromuscular block in neonates, infants and children
15. The neuromuscular blocking effects of vecuronium during sevoflurane, halothane and balanced anaesthesia in children
16. Neuromuscular effects of atracurium in infants and children
17. Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation